Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs
Goal: Educate providers and immunization staff personnel on the proper use of the Pfizer-BioNTech COVID-19 Vaccine
Session topics include:
- Introduction of the DO NOT DILUTE / Gray Cap formulation for individuals 12 years of age and older.
- Use of each vaccine presentation, including storage, handling, preparation, and administration for:
- Ages 5 through 11 Years: DILUTE BEFORE USE/Orange Cap
- Ages 12 Years and Older:
- DO NOT DILUTE/Gray Cap
- DILUTE BEFORE USE/Purple Cap
- Recent medical updates regarding the vaccine
- An overview of healthcare provider resources
- Question and answer session
These sessions will be updated to reflect new information and changes that evolve. Recent updates will be identified at the start of each session.
To access dates and links for upcoming training sessions, please visit:
https://www.pfizermedicalinformation.com/en-us/medical-updates
Or
Join the sessions at the designated times listed below:
Schedule through January 2022. Check the website for 2022 training sessions
|
Date & Time |
Password |
|---|---|
|
7TPd4QgG6kM |
|
|
5Q4fggcppc2 |
|
|
kpRpN6Kk5P5 |
|
|
xmBqyuSr252 |
|
|
ZnuC32Puqy5 |
|
|
|
|
|
D9ufVHMSM99 |
|
|
H3WuiDZtd22 |
|
|
gpPQjEdZ494 |
|
|
cVST3X9Rff2 |
|
|
ybW7Pnf6nN2 |
|
|
|
|
|
TupjKrQv427 |
|
|
BTt8MrXwR58 |
|
|
|
|
|
47DiG6JXsgA |
|
|
dwQkMZmJ258 |
|
|
|
|
|
mUvPGt6CG46 |
|
|
9Ec2MW8HWwp |
|
|
QmagnVap422 |
|
|
|
|
|
cKXFZSiW634 |
|
|
v9MUab6Yrd6 |
|
|
BXke23nMVD3 |
|
|
|
|
|
FJjvmeG327W |
|
|
kMapPATn986 |
|
|
grB3WCzru23 |
|
|
|
|
|
AQqwYfKE522 |
|
|
2pSQT324TdC |
|
|
yVDHYiaF828 |
*Weblinks for future training sessions will be updated, please visit the website https://www.pfizermedicalinformation.com/en-us/medical-updates for the most current training dates and times.
Continuing medical education is NOT associated with this event
Emergency uses of the vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 5 years of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at www.cvdvaccine-us.com.
Before administration of the vaccine, please see full Prescribing Information (16+ years of age) and EUA Fact Sheets for Vaccination Providers: 12 years of age and older (DILUTE BEFORE USE/Purple cap); 12 years of age and older (DO NOT DILUTE/Gray cap) and 5 through 11 years of age (DILUTE PRIOR TO USE/Orange cap)